BackMedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Overview
MedTech Acquisition Corp - Units (1 Ord Share Class A & 1/3 War)

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Return on Equity

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) (MTACU) has a ROE of -895.8%, below the sector sector average of -4.47%.

Get informed when a big investor buys or sells

+ Follow

ROE

-895.80%

Return on Equity

-895.80%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) (MTACU) FAQ

As of the most recent data, MTACU shows a ROE of -895.8%. That is below the sector sector average of -4.47%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about -4.47%. MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) is at -895.8%, which is lower that average. That is roughly 19947.7% below the sector mean. Use the comparison chart on this page to see how MTACU stacks up against individual peers as well.

Check the historical chart to see whether MTACU's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -895.8%) with ownership activity and broader fundamentals.